The impaired signaling via the CaSR pathway in these disorders results in a higher set-point for the CaSR, which leads to hypercalcemia in association with plasma PTH concentrations that are in the normal reference range (~ 80%) or elevated [30]. The gene discussed is PTH; the disease is hypercalcemia disease.